Transcutaneous posterior tibial nerve stimulation in pediatric overactive bladder: A preliminary report

Transcutaneous PTNS is superior to placebo in treatment of non-neurogenic overactive bladder in children. In view of its effectiveness and acceptability we believe that transcutaneous PTNS should be part of pediatric urology armamentarium for treatment of OAB.Table. Assessment of parameters between groups before and after neuromodulation.GroupInterventionIncontinenceAVV (mL)MVV (mL)NV (no.)NoMildModerateSevereTest N = 21Before PTNS07 (33.33%)8 (38%)6 (28.5%)68 (57-103)116 (90-205)11 (10-13)After PTNS15 (71.42%)5 (23.81%)1 (4.76%)089 (69-140)190 (120-300)7 (6-11)Sham N = 16Before PTNS05 (31.25%)7 (43.75%)4 (25%)74 (49-98)110 (88-193)10 (9-13)After PTNS2 (12.5%)5 (31.25%)6 (37.5%)3 (18.75%)79.5 (55-100)145.5 (105-200)10 (7-12)Note. PTNS = posterior tibial nerve stimulation; AVV = average voided volume; MVV = maximum voided volume; NV = number of voids.